MedPath

4 Versus 6 cm Active Phase of Labour

Completed
Conditions
Labor Complication
Cervix; Open
Interventions
Other: oxytocin augmentation
Registration Number
NCT05339399
Lead Sponsor
National University of Malaysia
Brief Summary

A study to compare maternal and perinatal outcome between 4 and 6 cm cervical dilatation at amniotomy.

Detailed Description

Low risk women with singleton pregnancy are recruited. There are two groups which are 4 and 6 cm cervical os dilatation. The intrapartum management and labour outcomes are documented.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
155
Inclusion Criteria
  • singleton pregnancy
  • no medical disorders
  • no antenatal complications such as hypertension and diabetes
Exclusion Criteria
  • fetal anomaly
  • one previous caesarean section
  • other uterine scars

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
4 cm cervical os dilatationoxytocin augmentationLow risk women with cervical os dilatation of 4 cm at amniotomy and whether they need oxytocin augmentation and analgesia.
6 cm cervical os dilatationoxytocin augmentationLow risk women with cervical os dilatation of 6 cm at amniotomy and whether they need oxytocin augmentation and analgesia.
Primary Outcome Measures
NameTimeMethod
Caesarean section ratefrom recruitment up to birth of neonate

in percentage

Secondary Outcome Measures
NameTimeMethod
duration from amniotomy until deliveryfrom recruitment until up to delivery of neonate

duration in minutes from recruitment until delivery

oxytocin augmentationfrom recruitment until up to delivery of neonate

percentage of those who required

Percentage of women with complicationsfrom recruitment until up to 6 weeks post delivery

complications such as postpartum haemorrhage and extended perineal tear

Percentage of neonates with complicationsfrom birth of neonate up tom 7 days

neonatal intensive care unit admission, Apgar score less than 7 at 5 minutes and cord pH \<7.24

Trial Locations

Locations (1)

National University of Malaysia

🇲🇾

Cheras, Kuala Lumpur, Malaysia

© Copyright 2025. All Rights Reserved by MedPath